Back to 
FMR LLC
FMR LLC
BCLI
Showing 0 of 17 quarters
Position history for FMR LLC's holdings in BRAINSTORM CELL THERAPEUTICS
No. FMR exited its BCLI (Brainstorm Cell Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 127 shares worth $35. FMR already held BCLI in its Q3 2019 13F, the earliest on record, and held it in 12 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.